Cavernous angioma cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Since cavernous angioma can be treated via medical or surgical option, therapy for this condition is relatively cost-effective. | Since [[cavernous angioma]] can be treated via [[medical]] or [[surgical option]], [[therapy]] for this condition is relatively [[cost-effective]]. | ||
<br /> | <br /> | ||
Revision as of 12:08, 11 March 2022
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma cost-effectiveness of therapy |
|
Risk calculators and risk factors for Cavernous angioma cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Since cavernous angioma can be treated via medical or surgical option, therapy for this condition is relatively cost-effective.
Cost-effectiveness of therapy
- Since cavernous angioma can be treated via medical or surgical option, therapy for this condition is relatively cost-effective.
- Single-fraction gamma-knife radiosurgery is one optional treatment that offers improvement in cost-effectiveness of therapy. [1]
References
- ↑ Tripathi M, Batish A, Kumar N, Ahuja CK, Oinam AS, Kaur R; et al. (2020). "Safety and efficacy of single-fraction gamma knife radiosurgery for benign confined cavernous sinus tumors: our experience and literature review". Neurosurg Rev. 43 (1): 27–40. doi:10.1007/s10143-018-0975-8. PMID 29633079.